Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 285, pseudogene (RN7SL285P) is a pseudogene derived from the human 7SL RNA, which is the RNA component of the signal recognition particle (SRP)[1][5]. The 7SL RNA itself is part of a ribonucleoprotein complex essential for co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum[3]. However, RN7SL285P is classified as a pseudogene, meaning it is a genomic DNA sequence resembling a functional gene (in this case, the 7SL RNA gene) but is not expressed as a functional RNA product[1][5]. The majority of 7SL RNA-like sequences in the human genome are pseudogenes, likely resulting from the reverse transcription and integration of 7SL RNA transcripts back into the genome[1][5]. Pseudogenes such as RN7SL285P are generally considered non-functional, although some exceptions exist where pseudogene-derived transcripts may play regulatory roles. There is no evidence that RN7SL285P has a biological function, therapeutic relevance, or disease association.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 285, pseudogene (RN7SL285P).